These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 33377756)

  • 1. Loop Diuretics: Clinical Application Information for Nephrology Nurses and Practitioners.
    Nguyen T
    Nephrol Nurs J; 2020; 47(6):553-572. PubMed ID: 33377756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comprehensive review of the loop diuretics: should furosemide be first line?
    Wargo KA; Banta WM
    Ann Pharmacother; 2009 Nov; 43(11):1836-47. PubMed ID: 19843838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diuretic therapy in acute heart failure].
    Trullàs JC; Morales-Rull JL; Formiga F
    Med Clin (Barc); 2014 Mar; 142 Suppl 1():36-41. PubMed ID: 24930082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative Effect of Loop Diuretic Prescription on Mortality and Heart Failure Readmission.
    Virkud AV; Chang PP; Funk MJ; Kshirsagar AV; Edwards JK; Pate V; Kosorok MR; Gower EW
    Am J Cardiol; 2024 Jan; 210():208-216. PubMed ID: 37972425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loop diuretics in patients with heart failure: time to change to torsemide?
    Pitt B; Nicklas J
    J Cardiovasc Pharmacol; 2009 Jun; 53(6):435-7. PubMed ID: 19430308
    [No Abstract]   [Full Text] [Related]  

  • 6. Diuretics in clinical practice. Part I: mechanisms of action, pharmacological effects and clinical indications of diuretic compounds.
    Sarafidis PA; Georgianos PI; Lasaridis AN
    Expert Opin Drug Saf; 2010 Mar; 9(2):243-57. PubMed ID: 20095917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function.
    De Vecchis R; Ciccarelli A; Ariano C; Cioppa C; Giasi A; Pucciarelli A; Cantatrione S
    Minerva Cardioangiol; 2011 Dec; 59(6):543-54. PubMed ID: 21330961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An evaluation of torsemide in patients with heart failure and renal disease.
    Peters AE; Mentz RJ; DeWald TA; Greene SJ
    Expert Rev Cardiovasc Ther; 2022 Jan; 20(1):5-11. PubMed ID: 34936522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of the loop diuretic torsemide in three dogs with advanced heart failure.
    Oyama MA; Peddle GD; Reynolds CA; Singletary GE
    J Vet Cardiol; 2011 Dec; 13(4):287-92. PubMed ID: 22030290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal actions of piretanide and three other "loop" diuretics.
    McNabb WR; Noormohamed FH; Brooks BA; Lant AF
    Clin Pharmacol Ther; 1984 Mar; 35(3):328-37. PubMed ID: 6697640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blind randomized crossover trial of two loop diuretics in chronic kidney disease.
    Vasavada N; Saha C; Agarwal R
    Kidney Int; 2003 Aug; 64(2):632-40. PubMed ID: 12846760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effectiveness of loop diuretics on mortality in the treatment of patients with chronic heart failure - A multicenter propensity score matched analysis.
    Täger T; Fröhlich H; Grundtvig M; Seiz M; Schellberg D; Goode K; Kazmi S; Hole T; Katus HA; Atar D; Cleland JGF; Agewall S; Clark AL; Frankenstein L
    Int J Cardiol; 2019 Aug; 289():83-90. PubMed ID: 30827731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diuretics].
    Schwartz J; Bloch R; Imbs JL; Spach MO
    Pathol Biol (Paris); 1986 Sep; 34(7):861-85. PubMed ID: 3537932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Torsemide versus furosemide and intermediate-term outcomes in patients with heart failure: an updated meta-analysis.
    Miles JA; Hanumanthu BK; Patel K; Chen M; Siegel RM; Kokkinidis DG
    J Cardiovasc Med (Hagerstown); 2019 Jun; 20(6):379-388. PubMed ID: 30950982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of continuous-infusion loop diuretics in critically ill children.
    Miller JL; Thomas AN; Johnson PN
    Pharmacotherapy; 2014 Aug; 34(8):858-67. PubMed ID: 24897942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probable loop diuretic-induced pancreatitis in a sulfonamide-allergic patient.
    Juang P; Page RL; Zolty R
    Ann Pharmacother; 2006 Jan; 40(1):128-34. PubMed ID: 16352777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy of diuretics in acute and chronic renal failure. Focus on torasemide.
    Risler T; Krämer B; Müller GA
    Drugs; 1991; 41 Suppl 3():69-79. PubMed ID: 1712716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coadministration of thiazides increases the efficacy of loop diuretics even in patients with advanced renal failure.
    Fliser D; Schröter M; Neubeck M; Ritz E
    Kidney Int; 1994 Aug; 46(2):482-8. PubMed ID: 7967362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Comprehensive Review of the Pharmacologic Perspective on Loop Diuretic Drug Interactions with Therapeutically Used Drugs.
    Maideen NMP; Balasubramanian R; Muthusamy S
    Curr Drug Metab; 2022; 23(3):188-199. PubMed ID: 35366769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [When do combinations of diuretics make sense?].
    Fuster D
    Ther Umsch; 2009 Nov; 66(11):725-9. PubMed ID: 19885788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.